18F-FDG PET or PET/CT for detecting extensive disease in small-cell lung cancer: A systematic review and meta-analysis

Yu Yu Lu, Jin Hua Chen, Ji An Liang, Shannon Chu, Wan Yu Lin, Chia Hung Kao

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The purpose of this study was to conduct a systematic review and meta-analysis of the published literature to evaluate the diagnostic accuracy of fluorine-18 2-fluoro-2-deoxy-D-glucose (F-FDG) PET or PET/computed tomography (CT) in the pretherapeutic staging of patients with small-cell lung cancer (SCLC). The authors conducted a systematic MEDLINE search of published articles. Two reviewers independently assessed the methodological quality of each study. We estimated the pooled sensitivity, specificity, positive and negative likelihood ratios (LR+ and LR-), and summary receiver operating characteristic curves in the detection of extensive disease (ED) in patients with SCLC. Twelve studies with a total of 369 patients met the inclusion criteria. The pooled estimates of sensitivity, specificity, LR+, and LR-of F-FDG PET or PET/CT for the detection of ED in SCLC were 97.5% [95% confidence interval (CI), 94.2-99.2%], 98.2% (95% CI, 94.9-99.6%), 19.86 (95% CI, 9.79-40.30), and 0.06 (95% CI, 0.03-0.10), respectively. Whole-body F-FDG PET or PET/CT is a valuable imaging tool for the pretherapeutic assessment of ED in patients with SCLC.

Original languageEnglish
Pages (from-to)697-703
Number of pages7
JournalNuclear Medicine Communications
Volume35
Issue number7
DOIs
Publication statusPublished - 2014

Fingerprint

Fluorodeoxyglucose F18
Small Cell Lung Carcinoma
Fluorine
Meta-Analysis
Tomography
Confidence Intervals
Sensitivity and Specificity
MEDLINE
ROC Curve

Keywords

  • PET/CT
  • small-cell lung cancer
  • staging

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Medicine(all)

Cite this

18F-FDG PET or PET/CT for detecting extensive disease in small-cell lung cancer : A systematic review and meta-analysis. / Lu, Yu Yu; Chen, Jin Hua; Liang, Ji An; Chu, Shannon; Lin, Wan Yu; Kao, Chia Hung.

In: Nuclear Medicine Communications, Vol. 35, No. 7, 2014, p. 697-703.

Research output: Contribution to journalArticle

Lu, Yu Yu ; Chen, Jin Hua ; Liang, Ji An ; Chu, Shannon ; Lin, Wan Yu ; Kao, Chia Hung. / 18F-FDG PET or PET/CT for detecting extensive disease in small-cell lung cancer : A systematic review and meta-analysis. In: Nuclear Medicine Communications. 2014 ; Vol. 35, No. 7. pp. 697-703.
@article{075f591bf9864d16b5d57c72e9999525,
title = "18F-FDG PET or PET/CT for detecting extensive disease in small-cell lung cancer: A systematic review and meta-analysis",
abstract = "The purpose of this study was to conduct a systematic review and meta-analysis of the published literature to evaluate the diagnostic accuracy of fluorine-18 2-fluoro-2-deoxy-D-glucose (F-FDG) PET or PET/computed tomography (CT) in the pretherapeutic staging of patients with small-cell lung cancer (SCLC). The authors conducted a systematic MEDLINE search of published articles. Two reviewers independently assessed the methodological quality of each study. We estimated the pooled sensitivity, specificity, positive and negative likelihood ratios (LR+ and LR-), and summary receiver operating characteristic curves in the detection of extensive disease (ED) in patients with SCLC. Twelve studies with a total of 369 patients met the inclusion criteria. The pooled estimates of sensitivity, specificity, LR+, and LR-of F-FDG PET or PET/CT for the detection of ED in SCLC were 97.5{\%} [95{\%} confidence interval (CI), 94.2-99.2{\%}], 98.2{\%} (95{\%} CI, 94.9-99.6{\%}), 19.86 (95{\%} CI, 9.79-40.30), and 0.06 (95{\%} CI, 0.03-0.10), respectively. Whole-body F-FDG PET or PET/CT is a valuable imaging tool for the pretherapeutic assessment of ED in patients with SCLC.",
keywords = "PET/CT, small-cell lung cancer, staging",
author = "Lu, {Yu Yu} and Chen, {Jin Hua} and Liang, {Ji An} and Shannon Chu and Lin, {Wan Yu} and Kao, {Chia Hung}",
year = "2014",
doi = "10.1097/MNM.0000000000000122",
language = "English",
volume = "35",
pages = "697--703",
journal = "Nuclear Medicine Communications",
issn = "0143-3636",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - 18F-FDG PET or PET/CT for detecting extensive disease in small-cell lung cancer

T2 - A systematic review and meta-analysis

AU - Lu, Yu Yu

AU - Chen, Jin Hua

AU - Liang, Ji An

AU - Chu, Shannon

AU - Lin, Wan Yu

AU - Kao, Chia Hung

PY - 2014

Y1 - 2014

N2 - The purpose of this study was to conduct a systematic review and meta-analysis of the published literature to evaluate the diagnostic accuracy of fluorine-18 2-fluoro-2-deoxy-D-glucose (F-FDG) PET or PET/computed tomography (CT) in the pretherapeutic staging of patients with small-cell lung cancer (SCLC). The authors conducted a systematic MEDLINE search of published articles. Two reviewers independently assessed the methodological quality of each study. We estimated the pooled sensitivity, specificity, positive and negative likelihood ratios (LR+ and LR-), and summary receiver operating characteristic curves in the detection of extensive disease (ED) in patients with SCLC. Twelve studies with a total of 369 patients met the inclusion criteria. The pooled estimates of sensitivity, specificity, LR+, and LR-of F-FDG PET or PET/CT for the detection of ED in SCLC were 97.5% [95% confidence interval (CI), 94.2-99.2%], 98.2% (95% CI, 94.9-99.6%), 19.86 (95% CI, 9.79-40.30), and 0.06 (95% CI, 0.03-0.10), respectively. Whole-body F-FDG PET or PET/CT is a valuable imaging tool for the pretherapeutic assessment of ED in patients with SCLC.

AB - The purpose of this study was to conduct a systematic review and meta-analysis of the published literature to evaluate the diagnostic accuracy of fluorine-18 2-fluoro-2-deoxy-D-glucose (F-FDG) PET or PET/computed tomography (CT) in the pretherapeutic staging of patients with small-cell lung cancer (SCLC). The authors conducted a systematic MEDLINE search of published articles. Two reviewers independently assessed the methodological quality of each study. We estimated the pooled sensitivity, specificity, positive and negative likelihood ratios (LR+ and LR-), and summary receiver operating characteristic curves in the detection of extensive disease (ED) in patients with SCLC. Twelve studies with a total of 369 patients met the inclusion criteria. The pooled estimates of sensitivity, specificity, LR+, and LR-of F-FDG PET or PET/CT for the detection of ED in SCLC were 97.5% [95% confidence interval (CI), 94.2-99.2%], 98.2% (95% CI, 94.9-99.6%), 19.86 (95% CI, 9.79-40.30), and 0.06 (95% CI, 0.03-0.10), respectively. Whole-body F-FDG PET or PET/CT is a valuable imaging tool for the pretherapeutic assessment of ED in patients with SCLC.

KW - PET/CT

KW - small-cell lung cancer

KW - staging

UR - http://www.scopus.com/inward/record.url?scp=84902267172&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902267172&partnerID=8YFLogxK

U2 - 10.1097/MNM.0000000000000122

DO - 10.1097/MNM.0000000000000122

M3 - Article

C2 - 24694775

AN - SCOPUS:84902267172

VL - 35

SP - 697

EP - 703

JO - Nuclear Medicine Communications

JF - Nuclear Medicine Communications

SN - 0143-3636

IS - 7

ER -